Selected cannabis cultivars modulate glial activation: in vitro and in vivo studies
Abstract Introduction Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by neuroinflammation, demyelination and axonal loss. Cannabis, an immunomodulating agent, is known for its ability to treat MS effectively. However, due to variations in the prof...
Saved in:
Main Authors: | Sigal Fleisher-Berkovich (Author), Nitzan Sharon (Author), Yvonne Ventura (Author), Valeria Feinshtein (Author), Jonathan Gorelick (Author), Nirit Bernstein (Author), Shimon Ben-Shabat (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Medicinal Cannabis: Evolution of therapeutic use, future approaches and other implications
by: Paola Brusa, et al.
Published: (2022) -
Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II
by: Francesca Baratta, et al.
Published: (2023) -
Cannabidiol-Loaded Nanoparticles Based on Crosslinked Starch: Anti-Inflammatory Activity and Improved Nose-to-Brain Delivery
by: Ilya Eydelman, et al.
Published: (2023) -
Genome-wide identification of cannabinoid biosynthesis genes in non-drug type Cannabis (Cannabis sativa L.) cultivar
by: Benny Jian Rong Sng, et al.
Published: (2024) -
Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
by: Milica Markovic, et al.
Published: (2020)